New diabetes clinical trial: A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
Published on: June 29, 2020 at 09:30PM
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY3209590; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/2Vt6awm
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY3209590; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/2Vt6awm
Comments
Post a Comment